Inventor · disambiguated record
Staci Sabnis
Also filed as: SABNIS STACI
16 granted patents·11 pending applications·192 citations·filing 2014–2023
93Inventor score
Top patents by PatentIndex Score
27 records- 0198US10207010B2Compositions and methods for delivery of agentsMODERNATX INC·Filed 2017·Granted Feb 19, 2019·104 cites·24 claims
- 0297US11285222B2Compositions and methods for delivery of agentsMODERNATX INC·Filed 2019·Granted Mar 29, 2022·10 cites·31 claims
- 0397US9925277B2Polynucleotide compositions containing amino acidsMODERNATX INC·Filed 2014·Granted Mar 27, 2018·26 cites·14 claims
- 0492US10485885B2Compositions and methods for delivery of agentsMODERNATX INC·Filed 2018·Granted Nov 26, 2019·8 cites·30 claims
- 0591US11001861B2Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1MODERNATX INC·Filed 2017·Granted May 11, 2021·11 cites·50 claims
- 0691US10494636B2Polynucleotides encoding α-galactosidase A for the treatment of Fabry diseaseMODERNATX INC·Filed 2018·Granted Dec 3, 2019·3 cites·8 claims
- 0791US10258698B2Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositionsMODERNATX INC·Filed 2014·Granted Apr 16, 2019·12 cites·6 claims
- 0890US10556018B2Compositions and methods for delivery of agentsMODERNATX INC·Filed 2017·Granted Feb 11, 2020·6 cites·28 claims
- 0987US11969506B2Lipid nanoparticle formulationMODERNATX INC·Filed 2018·Granted Apr 30, 2024·8 cites·13 claims
- 1084US11649461B2Polynucleotides encoding α-galactosidase A for the treatment of Fabry diseaseMODERNATX INC·Filed 2019·Granted May 16, 2023·1 cites·21 claims
- 1184US10993918B2Polynucleotides encoding citrin for the treatment of Citrullinemia type 2MODERNATX INC·Filed 2017·Granted May 4, 2021·2 cites·50 claims
- 1282US2023323371A1Polynucleotides encoding alpha-galactosidase a for the treatment of fabry diseaseMODERNATX INC·Filed 2023·Application pending·0 cites
- 1381US12491260B2Compositions and methods for delivery of agentsMODERNATX INC·Filed 2022·Granted Dec 9, 2025·0 cites·20 claims
- 1478US10519455B2Polynucleotides encoding alpha-galactosidase A for the treatment of Fabry diseaseMODERNATX INC·Filed 2018·Granted Dec 31, 2019·1 cites·29 claims
- 1577US2024318187A1Polyribonucleotides containing reduced uracil content and uses thereofMODERNATX INC·Filed 2023·Application pending·0 cites
- 1675US12377136B2Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyriaMODERNATX INC·Filed 2022·Granted Aug 5, 2025·0 cites·11 claims
- 1769US12252704B2Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1MODERNATX INC·Filed 2021·Granted Mar 18, 2025·0 cites·23 claims
- 1868US12239742B2Polynucleotides encoding Citrin for the treatment of Citrullinemia type 2MODERNATX INC·Filed 2021·Granted Mar 4, 2025·0 cites·3 claims
- 1968US2023027864A1Compositions and methods for delivery of agents to immune cellsMODERNATX INC·Filed 2022·Application pending·0 cites
- 2061US2019314291A1Compositions and methods for delivery of agents to immune cellsMODERNATX INC·Filed 2019·Application pending·0 cites
- 2159US2018214579A1Polynucleotide compositions containing amino acidsMODERNATX INC·Filed 2018·Application pending·0 cites
- 2258US2019142971A1Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositionsMODERNATX INC·Filed 2018·Application pending·0 cites
- 2354US2020085916A1Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyriaMODERNATX INC·Filed 2017·Application pending·0 cites
- 2453US2019382774A1Polyribonucleotides containing reduced uracil content and uses thereofMODERNATX INC·Filed 2017·Application pending·0 cites
- 2551US2023233475A1Lipid nanoparticles containing polynucleotides encoding glucose-6-phosphatase and uses thereofMODERNATX INC·Filed 2021·Application pending·0 cites
- 2645US2022296517A1Compositions and methods for enhanced delivery of agentsMODERNA TX INC·Filed 2020·Application pending·0 cites
- 2741US2019298657A1Polynucleotides Encoding Acyl-CoA Dehydrogenase, Very Long-Chain for the Treatment of Very Long-Chain Acyl-CoA Dehydrogenase DeficiencyMODERNATX INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Staci Sabnis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →